Inactive Instrument

Corium International Inc Stock

Equities

Duration

Period

Style

Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease	20-01-27	GL
Corium Appoints Perry Sternberg as Chief Executive Officer	19-04-02	GL
Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025	18-12-17	GL
Corium International : RM LAW Announces Investigation of Corium International, Inc.	18-10-15	PR
Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares	18-10-11	GL

Managers	Title	Age	Since
Perry J. Sternberg CEO	Chief Executive Officer	55	19-03-31
John Miller DFI	Director of Finance/CFO	-	-
Charles Oh CTO	Chief Tech/Sci/R&D Officer	-	-

Members of the board	Title	Age	Since
Brooks William Andrews BRD	Director/Board Member	-	-
David S. Moore BRD	Director/Board Member	50	-
Perry J. Sternberg		55	-

Sector